Latest HFSA News
Novel Nerve Ablation Procedure Explored for HFpEF
CLEVELAND -- Splanchnic nerve ablation was safe in heart failure with preserved…
Copper-Boosting Agent Promising for Low Ejection Fraction Heart Failure
CLEVELAND -- Lower doses of copper chelator trientine hydrochloride (Syprine) appeared safe…
Modest Risks Come With Moving Fast on HF Drugs After Acute Event
CLEVELAND -- Adverse events were common with rapid initiation and titration of…
Vagus Nerve Stimulation in Limbo for HFrEF
CLEVELAND -- Whether vagal nerve stimulation improved outcomes for heart failure patients…
Biomarker-Based CardioMEMS Candidates Benefit Less
CLEVELAND -- Elevated natriuretic peptides didn't select for patients that got as…
FDA Turns Down ATTR Cardiomyopathy Drug
CLEVELAND -- In a surprise Monday morning move, the FDA declined to…
Weight-Loss Drug Benefit Spans HFpEF, HFmrEF
CLEVELAND -- Semaglutide 2.4 mg (Wegovy) improved outcomes across the range of…
